Evidence map›Paper›PMID 14691460›Full record

ArticleOncogene2004

TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells.

Lars Guelen, Hugh Paterson, Joop Gäken, Michelle Meyers, Farzin Farzaneh, Mahvash Tavassoli

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 132 citations in OpenAlex.

  1. Molecular Characterization ofInternational journal of molecular sciences · 2026
    Article
  2. Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability.International journal of molecular sciences · 2025
    Article
  3. Article
  4. Gyrovirus: current status and challenge.Frontiers in microbiology · 2024
    Review
  5. Article
  6. Article
  7. The Role of Apoptin in Chicken Anemia Virus Replication.Pathogens (Basel, Switzerland) · 2020
    Review
  8. Article
  9. Apoptosis Triggered by ORF3 Proteins of theFrontiers in cellular and infection microbiology · 2020
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lars GuelenHead and Neck Oncology Group, Department of Oral Medicine and Pathology, The Rayne Institute, Guy's, King's and St Thomas' School of Medicine and Dentistry, London, UK.
Hugh Paterson
Joop Gäken
Michelle Meyers
Farzin Farzaneh
Mahvash Tavassoli
Institute of Cancer Research · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apoptin has been described to induce apoptosis in various human cancer cell lines, but not in normal cells, thus making it an interesting candidate for the development of novel therapeutic strategies. Apoptin was generated and cloned into several mammalian expression vectors. Transfection or microinjection of apoptin cDNA resulted in its expression, initially in the cytoplasm with a filamentous pattern. Subsequently, apoptin entered the nucleus and efficiently induced apoptosis in several cancer cell lines. Nuclear localization was shown to be required for induction of apoptosis. Apoptin expression level was found to be an important determinant of the efficiency of induction of apoptosis. Surprisingly, expression of apoptin or GFP-apoptin cDNA induced apoptosis in some normal cells. When fused to the HIV-TAT protein transduction domain and delivered as a protein, TAT-apoptin was transduced efficiently (>90%) into normal and tumour cells. However, TAT-apoptin remained in the cytoplasm and did not kill normal 6689 and 1BR3 fibroblasts. In contrast TAT-apoptin migrated from the cytoplasm to the nucleus of Saos-2 and HSC-3 cancer cells resulting in apoptosis after 24 h. This study shows that apoptin is a powerful apoptosis-inducing protein with a potential for cancer therapy.

Indexed as

ApoptosisActive Transport, Cell NucleusCapsid ProteinsCell Line, TumorCell NucleusCytoplasmGene Products, tatGenetic TherapyGenetic VectorsGreen Fluorescent ProteinsHeLa CellsHumansKineticsLuminescent ProteinsNeoplasmsProtein Structure, TertiaryCapsid ProteinsGene Products, tatGreen Fluorescent ProteinsLuminescent ProteinsRecombinant Fusion ProteinsVP3 protein, Chicken anemia virus

Identifiers

PMID14691460
OpenAlexW2072721016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.